Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0112498B2 - - Google Patents
[go: Go Back, main page]

JPH0112498B2 - - Google Patents

Info

Publication number
JPH0112498B2
JPH0112498B2 JP57160391A JP16039182A JPH0112498B2 JP H0112498 B2 JPH0112498 B2 JP H0112498B2 JP 57160391 A JP57160391 A JP 57160391A JP 16039182 A JP16039182 A JP 16039182A JP H0112498 B2 JPH0112498 B2 JP H0112498B2
Authority
JP
Japan
Prior art keywords
housing
chamber
liquid
partition
partition wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57160391A
Other languages
Japanese (ja)
Other versions
JPS5949770A (en
Inventor
Kenichi Yamakoshi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP57160391A priority Critical patent/JPS5949770A/en
Publication of JPS5949770A publication Critical patent/JPS5949770A/en
Publication of JPH0112498B2 publication Critical patent/JPH0112498B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Reciprocating Pumps (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)

Description

【発明の詳細な説明】 I 発明の背景 (技術分野) 本発明は、医療用の薬液注入シリンジ、更に詳
しくは種々の薬液を長期間に亙つて微量ずつ持続
的に注入するための医療用微量薬液注入シリンジ
に関するものである。
[Detailed Description of the Invention] I. Background of the Invention (Technical Field) The present invention relates to a medical liquid injection syringe, more specifically, a medical liquid injection syringe for continuously injecting various medical liquids in minute amounts over a long period of time. This invention relates to a drug injection syringe.

(先行技術およびその問題点) 種々の薬液を患者等に持続的に注入するポンプ
は種々開発されているが、多くはベツドサイド用
を前提としており、患者が携行し軽度の作業がで
きる小型かつ軽量のポンプの開発については十分
とはいえず、また従来の多くのポンプは電気的動
力源を必要とし、機構が複雑であり、高価でもあ
る。
(Prior art and its problems) Various pumps have been developed to continuously infuse various drug solutions into patients, etc., but most of them are designed for bedside use, and are small and lightweight pumps that can be carried by patients and used for light work. Pumps have not been sufficiently developed, and many conventional pumps require electrical power sources, are complex, and are expensive.

このような中で、小型かつ軽量化することがで
き、また簡潔な機構とすることが可能なポンプと
して浸透圧を利用したポンプが知られている。こ
の浸透圧型のポンプは基本的には半透膜を介して
形成される一方の充填室に水を、他方の充填室に
所定濃度の水溶液を満たし、浸透圧差に基づく水
の水溶液側への移動による水溶液側の体積増加
を、投与すべき薬液を充填した隔室に伝え、隔室
から長時間持続して薬液を注出させる形式のもの
である。
Under these circumstances, a pump that utilizes osmotic pressure is known as a pump that can be made small and lightweight, and has a simple mechanism. This osmotic pump basically fills one filling chamber formed through a semipermeable membrane with water and the other filling chamber with an aqueous solution of a predetermined concentration, and moves the water to the aqueous solution side based on the osmotic pressure difference. The increase in volume on the aqueous solution side caused by this is transmitted to the compartment filled with the medicinal solution to be administered, and the medicinal solution is continuously poured out from the compartment for a long period of time.

しかし、従来の浸透圧型のポンプは、動静脈内
に薬液を持続的に投与するのに用いる場合、患者
が携行して軽度の作業が行える程十分に小型で、
軽量でしかも簡易な構造を持つに至つてはいな
い。また、従来は半透膜として平膜を用い、この
平膜状半透膜を水および水溶液の充填室間の隔壁
としても機能させているので、一旦ポンプサイズ
を決定すると、半透膜を介しての水の移動速度の
調節、すなわち薬液注出速度の調節を水溶液の濃
度のみで調節しなければならず、薬液注出速度の
選択の自由度が小さい。このため、小型軽量化し
た時注出量を十分大きくすることができない。さ
らに、注出速度の安定性あるいは薬液注出口の負
荷圧に対する不感応性等において、実用に供し得
る良好な特性を示すものは得られていない。
However, when conventional osmotic pumps are used to continuously administer drug solutions into arteries and veins, they are small enough that patients can carry them around for light work.
It has yet to be lightweight and have a simple structure. In addition, conventionally, a flat membrane is used as a semipermeable membrane, and this flat semipermeable membrane also functions as a partition between filling chambers for water and aqueous solutions. Adjustment of the movement speed of all water, that is, adjustment of the drug solution pouring speed, must be adjusted only by the concentration of the aqueous solution, and the degree of freedom in selecting the drug solution pouring speed is small. For this reason, when the size and weight are reduced, the pouring volume cannot be increased sufficiently. Furthermore, no material has been obtained that exhibits good properties that can be put to practical use, such as the stability of the pouring rate or the insensitivity to the load pressure of the chemical liquid pouring port.

このような実状に鑑み、本発明者は、先に、半
透膜として、いわゆるホローフアイバーを用いた
浸透圧型の注出ポンプについての提案を行つてい
る。
In view of these circumstances, the present inventor has previously proposed an osmotic-type dispensing pump using a so-called hollow eye bar as a semipermeable membrane.

この先の提案に係る注出ポンプでは、ホローフ
アイバーの長さ、細孔径、使用本数をかえること
により、同一のポンプサイズにて、薬液注出速度
を広範囲に選定することができる。
In the dispensing pump proposed above, by changing the length, pore diameter, and number of hollow fibers used, it is possible to select a drug solution dispensing speed over a wide range with the same pump size.

しかし、浸透圧を使用する限り浸透圧差を得る
為の濃度の異なる2液と、各々の液を収容する為
のスペースが不可欠であり、より一層の小型、軽
量化を推進する上の原理的な障害となつている。
However, as long as osmotic pressure is used, two liquids with different concentrations to obtain the osmotic pressure difference and a space to accommodate each liquid are essential, which is a fundamental problem in promoting further compactness and weight reduction. It has become an obstacle.

発明の目的 本発明はこのような実状に鑑みなされたもので
あつて、動・静脈内等への持続的薬液投与用など
として用いる時、患者が携行して軽度の作業がで
きる程小型かつ軽量で、しかも簡易な構造をもつ
医療用微量薬液注入シリンジを提供することを第
1の目的とする。
Purpose of the Invention The present invention was made in view of the above-mentioned circumstances, and is designed to be small and lightweight enough to be carried by a patient for light work when used for continuous administration of drug solutions into arteries and veins. The first object of the present invention is to provide a medical micro-drug injection syringe that has a simple structure.

本発明の第2の目的は、シリンジサイズの大小
に拘らず、薬液注出速度を広範に選択設定できる
医療用微量薬液注入シリンジを提供しようとする
にある。
A second object of the present invention is to provide a medical micro-drug injection syringe that allows a wide range of drug solution injection speeds to be selected and set, regardless of the size of the syringe.

本発明の第3の目的は、注出速度の安定性、負
荷圧不感応性とも実用に供し得る良好な特性を示
す医療用微量薬液注入シリンジを提供しようとす
るにある。
A third object of the present invention is to provide a medical micro-drug injection syringe that exhibits good characteristics in terms of stability in dispensing rate and insensitivity to load pressure for practical use.

本発明の第4の目的は、デイスポーザブル化が
可能な医療用微量薬液注入シリンジを提供しよう
とするにある。
A fourth object of the present invention is to provide a medical microdrug injection syringe that can be made disposable.

すなわち、本発明は、医療用に用いられる微量
薬液注入シリンジであつて、基端側に駆動手段、
末端に薬液注出口を具えるハウジング内に、該ハ
ウジングの末端側より順次に所定間隔離間して該
ハウジング内周壁に沿つて液密に摺動可能に形成
された第1隔壁と、該ハウジング内周壁に固着さ
れた第2隔壁と、該ハウジング内周壁に沿つて液
密に摺動可能に形成された第3隔壁と、前記ハウ
ジングと前記第1隔壁により形成された前記注出
口を含む薬液注出用の第1室と、前記ハウジング
と前記第1および前記第2隔壁とにより閉塞され
た液体充填用の第2室と、前記ハウジングと前記
第2および前記第3隔壁とにより閉塞された液体
充填用の第3室と、前記第2室と前記第3室との
間に設けられた微細多孔を有する少なくとも1本
のホローフアイバーからなり、かつ前記両室が前
記ホローフアイバーの微細多孔を経てのみ連通す
る連通孔とからなり、前記駆動手段は、前記ハウ
ジングの基端よりハウジング内に向けて装着され
たねじ軸と、該ねじ軸を前記ハウジング内に回転
可能でかつ軸方向に移動しないように取り付ける
ための手段と、前記ねじ軸に螺合されたナツト
と、該ナツトと前記第2隔壁の基端側の面との間
に設置されたばねとで構成され、前記ねじ軸の回
転により所定値に調整されたばね力により加圧さ
れた前記第3室の液体が前記ホローフアイバーを
経て前記第2室内に浸出することにより、加圧さ
れた前記第2室の液体が前記第1隔壁をハウジン
グの末端側に向けて変位させ、該第1隔壁の変位
量に応じて前記第1室内の薬液が前記注出口より
持続的に排出されるように構成した医療用微量薬
液注入シリンジである。
That is, the present invention is a micro-drug injection syringe used for medical purposes, which includes a driving means on the proximal end side;
A first partition wall is formed in a housing having a medical solution spout at its end, and is slidable liquid-tightly along the inner circumferential wall of the housing at predetermined intervals sequentially from the end side of the housing; A chemical liquid injector including a second partition wall fixed to a peripheral wall, a third partition wall formed to be slidable liquid-tightly along the inner peripheral wall of the housing, and the spout formed by the housing and the first partition wall. a first chamber for liquid filling; a second chamber for liquid filling that is closed by the housing and the first and second partitions; and a second chamber for liquid filling that is closed by the housing and the second and third partitions. A third chamber for filling, and at least one hollow eye bar having micro pores provided between the second chamber and the third chamber, and both chambers are connected to each other through the micro pores of the hollow eye bar. The drive means includes a screw shaft mounted from the base end of the housing toward the inside of the housing, and a screw shaft that is rotatable into the housing and prevented from moving in the axial direction. a nut screwed onto the screw shaft; and a spring installed between the nut and the proximal surface of the second partition wall, The liquid in the third chamber pressurized by the spring force adjusted to the specified value leaks into the second chamber through the hollow eye bar, so that the pressurized liquid in the second chamber moves the first partition into the housing. The medical micro-drug injection syringe is configured such that the medical liquid in the first chamber is continuously discharged from the spout according to the amount of displacement of the first partition wall.

本発の医療用微量薬液注入シリンジを添付図面
に示す好適実施例につき詳細に説明する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The medical micro-drug injection syringe of the present invention will be described in detail with reference to preferred embodiments shown in the accompanying drawings.

第1図は本発明の医療用微量薬液注入シリンジ
の好適例の縦断面図である。本発明のシリンジ1
の円筒状ハウジング2の末端側には薬液注出口3
が形成され、基端側には駆動手段4が設けられて
いる。ハウジング2内には、ハウジング2の末端
側から順次に適当な間隔離間して、ハウジング2
の内周壁に沿つて液密に摺動可能な第1隔壁5、
ハウジング2の内周壁に固着された第2隔壁6お
よび第1隔壁5と同様にハウジング2の内周壁に
沿つて液密に摺動可能な第3隔壁7が形成されて
いる。これにより、ハウジング2および第1隔壁
5によりハウジング2の薬液注出口を含む薬液充
填用の第1室8、ハウジング2、摺動可能な第1
隔壁5および固定の第2隔壁6により適当な液
体、好ましくは水充填用の第2室、およびハウジ
ング2、固定の第2隔壁6および摺動可能な第3
隔壁7により適当な液体、好ましくは水充填用の
第3室10が形成される。
FIG. 1 is a longitudinal sectional view of a preferred example of the medical micro-drug injection syringe of the present invention. Syringe 1 of the present invention
A drug solution spout 3 is provided on the distal side of the cylindrical housing 2.
is formed, and a driving means 4 is provided on the proximal end side. Inside the housing 2, the housing 2 is sequentially spaced apart from the distal end of the housing 2 by an appropriate distance.
a first partition wall 5 that is slidable liquid-tightly along the inner circumferential wall of the partition wall 5;
Similarly to the second partition wall 6 and the first partition wall 5 fixed to the inner peripheral wall of the housing 2, a third partition wall 7 is formed which can slide along the inner peripheral wall of the housing 2 in a liquid-tight manner. As a result, the housing 2 and the first partition wall 5 form a first chamber 8 for filling a medical liquid including a medical liquid spout in the housing 2, a first chamber 8 for filling the medical liquid including a medical liquid spout in the housing 2,
The partition 5 and the fixed second partition 6 form a second chamber for filling a suitable liquid, preferably water, and the housing 2, the fixed second partition 6 and the slidable third
The partition 7 forms a third chamber 10 for filling with a suitable liquid, preferably water.

第1および第3隔壁5および7はハウジング2
の内周壁を液密なるもできるだけ小さな抵抗で摺
動するように構成するのが良く、ガスケツトで構
成するのが好ましい。第1室8にはインスリンな
どの微量ずつ持続的に注入さるべき薬液が充填さ
れる。第2室9および第3室10には第1室8内
の薬液を注出する圧力を与えるための液体が充填
されるが、安全性から水が最も好ましい。特に、
第1室8の薬液中へ第2室9の液体が混入しない
ようにすることが重要である。
The first and third partition walls 5 and 7 are connected to the housing 2
It is preferable that the inner circumferential wall of the tube is liquid-tight and slidable with as little resistance as possible, and is preferably constructed of a gasket. The first chamber 8 is filled with a medicinal solution such as insulin that should be continuously injected in small amounts. The second chamber 9 and the third chamber 10 are filled with a liquid for applying pressure to pour out the medicinal solution in the first chamber 8, but water is most preferable from the viewpoint of safety. especially,
It is important to prevent the liquid in the second chamber 9 from mixing into the chemical liquid in the first chamber 8.

第2室9と第3室10との間は流体連通するよ
う構成する。固定隔壁6に少なくとも2個の連通
用の孔11を形成し、これらの孔間に後に詳述す
るような微細な孔を多数有するホローフアイバー
12を少なくとも1本張設し、液体浸出用の高抵
抗膜とする。これにより両室9および10はホロ
ーフアイバー12の微細孔を経てのみ連通してい
る。
The second chamber 9 and the third chamber 10 are configured to be in fluid communication. At least two holes 11 for communication are formed in the fixed partition wall 6, and at least one hollow eye bar 12 having a large number of fine holes as will be described in detail later is stretched between these holes to provide a height for liquid leaching. Use a resistive film. As a result, both chambers 9 and 10 communicate only through the fine holes of the hollow eye bar 12.

第2室9および第3室10の高抵抗流体連通に
用いるホローフアイバー12としては、微細な多
孔性の中空管であればいかなるものを用いても良
いが、再生セルロース製のものが最も望ましいこ
とが実験の結果判明した。ホローフアイバーとし
ては、孔径が10〜20Å、内径が200μm、外径が
230μmのものを多数本組み合わせて用いるのが
好ましい。
As the hollow fiber 12 used for high-resistance fluid communication between the second chamber 9 and the third chamber 10, any fine porous hollow tube may be used, but one made of regenerated cellulose is most preferable. This was revealed as a result of the experiment. Hollow eye bars have a pore diameter of 10 to 20 Å, an inner diameter of 200 μm, and an outer diameter of
It is preferable to use a combination of multiple pieces of 230 μm.

他方、ハウジング2の基端側には駆動手段4が
設けられる。駆動手段4は本発明においては、ハ
ウジング2の基端壁13に形成した開口14に回
転可能に取り付けたねじ軸15に螺合するナツト
16と摺動可能な第3隔壁7との間に張設した圧
縮コイルばね17で構成される。このばね17は
第3隔壁7上に形成したガイド18により案内す
るのが好ましい。ねじ軸14の末端には回転用ノ
ブ19を設け、またねじ軸14にはハウジング2
の基端壁13の内側において止め20を設け、ノ
ブ19および止め20によりねじ軸15の軸線方
向のぶれを防止する。なお、ノブ19の回転量す
なわち薬液の注出速度はノブ19に関連して設け
られた目盛等の指示手段(図示せず)により適当
に制御することができる。
On the other hand, a driving means 4 is provided on the proximal end side of the housing 2. In the present invention, the drive means 4 is provided between a nut 16 screwed onto a screw shaft 15 rotatably mounted in an opening 14 formed in the proximal wall 13 of the housing 2 and a slidable third partition wall 7. It is composed of a compression coil spring 17 provided. This spring 17 is preferably guided by a guide 18 formed on the third partition 7. A rotation knob 19 is provided at the end of the screw shaft 14, and a housing 2 is provided on the screw shaft 14.
A stop 20 is provided inside the proximal wall 13 of the screw shaft 15, and the knob 19 and the stop 20 prevent the screw shaft 15 from wobbling in the axial direction. Note that the amount of rotation of the knob 19, that is, the speed of dispensing the drug solution, can be appropriately controlled by indicating means (not shown), such as a scale, provided in connection with the knob 19.

発明の具体的作用 第1室8には所要の薬液が、第2室9および第
3室10には所要の液体がそれぞれ所要量充填さ
れた状態で、ねじ軸15をそのノブ19の回転に
より回転させると、このねじ軸15に螺合してい
るナツト16がハウジング2の末端側に向けて移
動し、コイルばね17を圧縮する。これによるば
ね圧は第3隔壁7を押圧してこれをハウジング2
の末端側に向けて押圧し、第3向け10内の液体
を加圧する。第3室10内の加圧液体はホローフ
アイバー12の微細孔より押し出され、第2室9
内に浸出する。すると、第2室9内の液体は加圧
または体積増加状態となるから、その力により第
1隔壁5がハウジング2の末端側に向けて押圧さ
れ移動する。この第1隔壁の移動量に応じて第1
室8内の薬液が注出口3を経て矢印21で示すよ
うに注出され、患者等に注入される。
Specific Effects of the Invention With the first chamber 8 filled with the required chemical solution, and the second chamber 9 and the third chamber 10 filled with the required amount of liquid, the screw shaft 15 is rotated by rotating the knob 19. When rotated, the nut 16 screwed onto the screw shaft 15 moves toward the distal end of the housing 2 and compresses the coil spring 17. The spring pressure caused by this presses the third partition wall 7 and pushes it against the housing 2.
toward the distal end of the tube to pressurize the liquid in the third tube 10. The pressurized liquid in the third chamber 10 is pushed out through the micropores of the hollow eye bar 12, and the pressurized liquid in the third chamber 10 is
leaches within. Then, the liquid in the second chamber 9 is pressurized or the volume increases, and this force presses and moves the first partition wall 5 toward the distal end of the housing 2. The first partition wall is moved according to the amount of movement of the first partition wall.
The medicinal solution in the chamber 8 is poured out through the spout 3 as shown by an arrow 21 and injected into a patient or the like.

必要に応じて、ノブ19を逐次的に所定量回転
させれば、上述した薬液の微量注出が繰り返し持
続的に長時間に亙つて行われる。
If the knob 19 is sequentially rotated by a predetermined amount as necessary, the above-described small amount of medicinal liquid is repeatedly dispensed continuously over a long period of time.

次に、本発明の医療用微量薬液注入シリンジの
作用を具体例につき説明する。
Next, the action of the medical micro-drug injection syringe of the present invention will be explained using a specific example.

第1図に示すような構造のシリンジを用いてシ
リンジ特性を測定した。その結果を第2図に示
す。ばねとしては、ねじ軸の回転によるナツトの
移動に伴うばね力低下を少なくするため、小さな
ばね定数(k=4.12×10-2Kg/mm)のばねを用い
た。ホローフアイバーとしては、内径200μm、
外径230μm、平均孔径10〜20Å、長さ10cmの再
生セルロース製のホローフアイバー18本用いた。
薬液注出端圧力はほぼ大気圧とし、流出流量は1
分間の流出量を電子天秤を用いて連続5回測定
し、その平均値とした。
Syringe characteristics were measured using a syringe having a structure as shown in FIG. The results are shown in FIG. As the spring, a spring with a small spring constant (k=4.12×10 -2 Kg/mm) was used in order to reduce the decrease in spring force caused by the movement of the nut due to the rotation of the screw shaft. As a hollow eye bar, the inner diameter is 200μm,
Eighteen hollow fiber eyelets made of regenerated cellulose having an outer diameter of 230 μm, an average pore diameter of 10 to 20 Å, and a length of 10 cm were used.
The chemical solution pouring end pressure is approximately atmospheric pressure, and the outflow flow rate is 1.
The amount of outflow per minute was measured five times in a row using an electronic balance, and the average value was taken as the average value.

第2のグラフにおいて、上部はばね力から換算
した圧力と薬液の流出流量との関係を示したもの
で、圧力と流出流量との直線性は良好で、この関
係は約2Kg/cm2まで維持された。また、第2図の
グラフにおいて、下部は上述のホローフアイバー
およびばねを用いた場合の圧力と総流出量との関
係を示したもので、初期圧P0を0.83Kg/cm2、摺動
可能な隔壁5の有効面積を3.14cm2とし、5mlまで
流出させた時の結果である。5mlまで流出するこ
とにより圧力は約25%減少している。従つて、こ
のばねを用いた場合、1.7ml流出時にばねをリワ
インドし、P0に設定し直すことにより、流出流
量の減少を8%以下に抑えられることがわかる。
このような流出流量の減少およびばねのリワイン
ドの問題は、ばね定数をより小さくすることによ
り容易に改善することができる。
In the second graph, the upper part shows the relationship between the pressure converted from the spring force and the outflow flow rate of the chemical solution.The linearity between the pressure and the outflow flow rate is good, and this relationship is maintained up to about 2 kg/ cm2 . It was done. In addition, in the graph in Figure 2, the lower part shows the relationship between pressure and total outflow when using the above-mentioned hollow eye bar and spring . This is the result when the effective area of the partition wall 5 is 3.14 cm 2 and up to 5 ml of water flows out. By outflowing to 5 ml, the pressure has decreased by about 25%. Therefore, it can be seen that when this spring is used, the decrease in the outflow flow rate can be suppressed to 8% or less by rewinding the spring and resetting it to P 0 when 1.7 ml flows out.
Such problems of reduced flow rate and spring rewind can be easily improved by making the spring constant smaller.

第3図は本発明の医療用微量薬液注入シリンジ
の負荷特性を、ばね力換算の圧力をパラメータと
して示したものである。これは上述したホローフ
アイバー10cmのものを25本用いた例について得ら
れたもので、負荷圧増加に伴い流出流量は減少傾
向を示しているが、理論曲線(図中実線で示す)
との差は数%以内で、充分実用に供しうるもので
ある。
FIG. 3 shows the load characteristics of the medical micro-drug injection syringe of the present invention using the pressure in terms of spring force as a parameter. This was obtained for an example using 25 hollow eye bars of 10 cm as described above, and the outflow flow rate shows a decreasing tendency as the load pressure increases, but the theoretical curve (shown by the solid line in the figure)
The difference is within several percent, which is sufficient for practical use.

発明の具体的効果 本発明の医療用微量薬液注入シリンジは従来の
ものに比して以下に述べるような多くの利点をも
たらすものである。
Specific Effects of the Invention The medical micro-drug injection syringe of the present invention has many advantages over conventional ones, as described below.

(1) シリンジ全体は極めて小型かつ軽量化でき、
しかも構造が簡易であり、薬液の持続的投与に
際してシリンジを携行し、しかも軽度の作業を
することができる。
(1) The entire syringe can be extremely small and lightweight;
In addition, the structure is simple, and the syringe can be carried around for continuous administration of drug solutions, and light work can be done.

(2) このシリンジは構造が簡易なため製作コスト
が低廉でデイスポーザブル化が可能であり、経
済性、感染に対する安全性という観点から有用
である。
(2) This syringe has a simple structure, so the manufacturing cost is low and it can be made disposable, making it useful from the viewpoint of economy and safety against infection.

(3) 電気動力源を用いず、機構部を殆ど持たない
ため、従来のような機械音による患者の心理的
負担がなくなる。
(3) Since it does not use an electric power source and has almost no mechanical parts, the psychological burden on patients caused by conventional mechanical noise is eliminated.

(4) 例え誤動作や駆動部の損傷部によりホローフ
アイバー中へ空気が混入しても、流出流量が減
少あるいは停止するだけで、体内への空気混入
や血液の逆流の恐れは全くない。
(4) Even if air gets mixed into the hollow eye bar due to a malfunction or a damaged part of the drive part, the outflow flow rate will simply decrease or stop, and there is no risk of air getting into the body or backflow of blood.

(5) 本発明では連通孔をホローフアイバーとする
のでホローフアイバーの長さ、有孔率、内外径
あるいは使用本数を選択的に変えることによ
り、薬液注出速度を広範囲に亙つて任意に変え
ることができる。
(5) In the present invention, the communicating holes are hollow fibers, so by selectively changing the length, porosity, inner and outer diameters of the hollow fibers, or the number of hollow fibers used, the liquid injection speed can be arbitrarily changed over a wide range. Can be done.

(6) 薬液注出速度は安定しており、また薬液注出
口端の負荷圧に対する不感応性も充分実用に供
しうる良好な特性を示す。
(6) The chemical solution pouring speed is stable, and the insensitivity to the load pressure at the end of the chemical solution pouring port shows good characteristics that can be used for practical purposes.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明の医療用微量薬液注入シリンジ
の部分断面図、第2図は、本発明において、上部
はばね力から換算した圧力と薬液の流出流量との
関係を、下部は圧力と総流出量との関係を示すグ
ラフ、第3図は本発明の医療用微量薬液注入シリ
ンジの負荷特性を、ばね力換算の圧力をパラメー
タとして示すグラフである。 符号の説明1 1…本発明の医療用微量薬液注
入シリンジ、2…ハウジング、3…薬液注出口、
4…駆動手段、5,7…摺動可能な隔壁、6…固
定隔壁、8…第1室、9…第2室、10…第3
室、11…孔、12…ホローフアイバー、13…
端壁、14…開口、15…ねじ軸、16…ナツ
ト、17…コイルばね、18…ガイド、19…ノ
ブ、20…止め、21…薬液注出方向。
Fig. 1 is a partial cross-sectional view of the medical micro-drug injection syringe of the present invention, and Fig. 2 shows the relationship between the pressure converted from the spring force and the outflow flow rate of the medicinal solution in the upper part, and the pressure and the total flow rate in the lower part. FIG. 3 is a graph showing the relationship with the outflow amount, and is a graph showing the load characteristics of the medical micro-drug injection syringe of the present invention using pressure in terms of spring force as a parameter. Explanation of symbols 1 1... Medical micro-drug injection syringe of the present invention, 2... Housing, 3... Medicinal solution spout,
4... Driving means, 5, 7... Slidable partition wall, 6... Fixed partition wall, 8... First chamber, 9... Second chamber, 10... Third chamber
Chamber, 11...hole, 12...hollow eye bar, 13...
End wall, 14... Opening, 15... Screw shaft, 16... Nut, 17... Coil spring, 18... Guide, 19... Knob, 20... Stop, 21... Chemical solution pouring direction.

Claims (1)

【特許請求の範囲】 1 医療用に用いられる微量薬液注入量薬液注入
シリンジであつて、 基端側に駆動手段、末端に薬液注出口を具える
ハウジング内に、該ハウジングの末端側より順次
に所定間隔離間して該ハウジング内周壁に沿つて
液密に摺動可能に形成された第1隔壁と、 該ハウジング内周壁に固着された第2隔壁と、 該ハウジング内周壁に沿つて液密に摺動可能に
形成された第3隔壁と、 前記ハウジングと前記第1隔壁により形成され
た前記注出口を含む薬液注出用の第1室と、 前記ハウジングと前記第1および前記第2隔壁
とにより閉塞された液体充填用の第2室と、 前記ハウジングと前記第2および前記第3隔壁
とにより閉塞された液体充填用の第3室と、 前記第2室と前記第3室との間に設けられた微
細多孔を有する少なくとも1本のホローフアイバ
ーからなり、かつ前記両室が前記ホローフアイバ
ーの微細多孔を経てのみ連通する連通孔とからな
り、 前記駆動手段は、前記ハウジングの基端よりハ
ウジング内に向けて装着されたねじ軸と、該ねじ
軸を前記ハウジング内に回転可能でかつ軸方向に
移動しないように取り付けるための手段と、 前記ねじ軸に螺合されたナツトと、 該ナツトと前記第2隔壁の基端側の面との間に
設置されたばねとで構成され、 前記ねじ軸の回転により所定値に調整されたば
ね力により加圧された前記第3室の液体が前記ホ
ローフアイバーを経て前記第2室内に浸出するこ
とにより、加圧された前記第2室の液体が前記第
1隔壁をハウジングの末端側に向けて変位させ、
該第1隔壁の変位量に応じて前記第1室内の薬液
が前記注出口より持続的に排出されるように構成
したことを特徴とする医療用微量薬液注入シリン
ジ。
[Scope of Claims] 1. A medical liquid injection syringe with a small amount of liquid medicine used for medical purposes, which is provided in a housing having a driving means at the proximal end and a liquid medicine spout at the distal end, and which is arranged in order from the distal end of the housing. a first partition wall formed to be slidable in a liquid-tight manner along the inner circumferential wall of the housing with a predetermined distance therebetween; a second partition wall fixed to the inner circumferential wall of the housing; a third partition wall formed to be slidable; a first chamber for dispensing the drug solution including the spout formed by the housing and the first partition wall; the housing and the first and second partition walls; a third chamber for liquid filling that is closed by the housing and the second and third partition walls; and between the second chamber and the third chamber. and a communication hole through which both chambers communicate with each other only through the micropores of the hollow fiber, and the driving means is arranged to extend from the proximal end of the housing. a screw shaft mounted toward the inside of the housing; means for rotatably and immovably mounting the screw shaft in the housing; a nut screwed onto the screw shaft; and the nut. and a spring installed between the surface of the base end side of the second partition, and the liquid in the third chamber pressurized by the spring force adjusted to a predetermined value by rotation of the screw shaft flows into the hollow. By seeping into the second chamber through the fiber, the pressurized liquid in the second chamber displaces the first partition toward a distal side of the housing;
A micro-dose medical liquid injection syringe, characterized in that the medical liquid in the first chamber is continuously discharged from the spout according to the amount of displacement of the first partition.
JP57160391A 1982-09-14 1982-09-14 Minute amount pump Granted JPS5949770A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57160391A JPS5949770A (en) 1982-09-14 1982-09-14 Minute amount pump

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57160391A JPS5949770A (en) 1982-09-14 1982-09-14 Minute amount pump

Publications (2)

Publication Number Publication Date
JPS5949770A JPS5949770A (en) 1984-03-22
JPH0112498B2 true JPH0112498B2 (en) 1989-03-01

Family

ID=15713940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57160391A Granted JPS5949770A (en) 1982-09-14 1982-09-14 Minute amount pump

Country Status (1)

Country Link
JP (1) JPS5949770A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0626569B2 (en) * 1987-11-11 1994-04-13 日機装株式会社 Micro-volume dispenser
JP2526658B2 (en) * 1989-03-10 1996-08-21 日立電線株式会社 Wind noise countermeasures for multi-conductor transmission lines
JP2559587Y2 (en) * 1990-07-04 1998-01-19 古河電気工業株式会社 Low wind noise multi-conductor transmission line

Also Published As

Publication number Publication date
JPS5949770A (en) 1984-03-22

Similar Documents

Publication Publication Date Title
US3964479A (en) Extracorporeal blood circulation system and drip chamber with adjustable blood level
US4753651A (en) Self-driven pump
US4340048A (en) Self-driven hypodermic injector
US7789853B2 (en) Infusion apparatus with constant force spring energy source
DE2652026C2 (en) Device for infusing liquids
US2627270A (en) Self-propelled automatic syringe
CA1210292A (en) Solution administration set
JP3207799B2 (en) Continuous chemical injector
US20120046651A1 (en) Medical device for glucose monitoring or regulation
EP2052677A1 (en) Medical device for glucose monitoring or regulation
JPH08509138A (en) Electrochemically controlled dosing assembly and method
GB2039849A (en) Liquid metering device
JPH02119871A (en) Portable infusion equipment assembly
KR102686994B1 (en) Method and device for generating injectable foam
JPH0515590A (en) Device for self-injection of drug solution and device using the same
USRE34365E (en) Intravenous system for delivering a beneficial agent
JPH0112498B2 (en)
JPS6259586B2 (en)
JPH0112499B2 (en)
JPH0687895B2 (en) Balloon Infuser
CN113262355B (en) Integrated piezoelectric driving intelligent insulin patch
JPH01135359A (en) Controller for feeding small amount of fluid
CN219049817U (en) Analgesic pump
CA2011629A1 (en) Intravenous system for delivering a beneficial agent
SU993954A1 (en) Device for injection of drug solutions